Answers are grounded in this paper and cite their sources.
CONTEXT: Septic shock is a major cause of morbidity and mortality in the pediatric population worldwide, and evidence comparing balanced crystalloids with normal saline (NS) for resuscitation remains inconclusive. OBJECTIVE: To compare balanced crystalloids with NS for fluid resuscitation in children with septic shock, incorporating recent randomized controlled trials (RCTs). DATA SOURCES: PubMed, Cochrane Central, and ClinicalTrials.gov were searched from inception to May 2026, without language restrictions. STUDY SELECTION: RCTs comparing balanced crystalloids with NS in patients aged 0 to 18 years with sepsis or septic shock were eligible. DATA EXTRACTION: Two reviewers independently extracted data and assessed risk of bias (Cochrane Risk of Bias 2 tool). Risk ratios (RRs) with 95% CIs were pooled using random-effects models; heterogeneity was assessed with the I2 statistic; leave-one-out and post hoc sensitivity analyses excluding the largest trial were performed. RESULTS: Six RCTs comprising 10,308 participants were included. RRs are reported with NS as the reference. Pooled mortality showed no statistical significance between groups (3.8% with balanced crystalloids vs. 4.0% with NS; RR, 0.93; 95% CI, 0.67-1.27; P = 0.63). Acute kidney injury incidence also did not differ significantly between groups (19.7% vs. 29.6%; RR, 0.76; 95% CI, 0.46-1.27; P = 0.29). The need for renal replacement therapy (RRT) was lower with balanced crystalloids (1.3% vs. 1.9%; RR, 0.67; 95% CI, 0.48-0.92; P = 0.01). Hyperchloremia incidence was lower with balanced crystalloids (32.3% vs. 49.9%; RR, 0.65; 95% CI, 0.61-0.69; P < 0.00001). After excluding the largest trial (PRoMPT BOLUS), mortality remained nonsignificant (RR, 0.82; 95% CI, 0.45-1.50), and the reductions in RRT (RR, 0.58; 95% CI, 0.39-0.87) and hyperchloremia (RR, 0.70; 95% CI, 0.59-0.82) persisted. CONCLUSIONS: Compared with NS, balanced crystalloids reduced the need for RRT and the incidence of hyperchloremia, without significantly affecting mortality or acute kidney injury.
No takes yet. Share an insight, caveat, or question.
Yousaf et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: